The global drug-eluting beads market is projected to grow at a CAGR of 5.6% during the forecast period and is predicted to be worth US$ 2.3 billion by 2028. The growth in this industry can be attributed to factors such as the increasing number of surgeries, the introduction of new products with enhanced efficacy, rising prevalence rates of cancer worldwide, and growing acceptance among patients for minimally invasive procedures. In the near future, it will become more cost-effective for hospitals to use these devices instead of other surgical methods that are more expensive and time-consuming.
Drug-eluting beads are tiny, biocompatible particles that contain a therapeutic agent and coated with an outer layer of polymer. The drug is released as the bead dissolves over time. They can be used to treat cancerous tumors in patients who have difficulty undergoing surgery or other treatment options due to their health conditions. Drug-eluting beads were initially introduced by Angiodynamics Inc., which was acquired by Boston Scientific Corporation in 1998 for US$ 301 million.
On the basis of type, the drug-eluting beads market is segmented into oncozene beads, quadra sphere, LC Beads, and others.
Oncozene beads, a type of drug-eluting bead, are used for the treatment of cancerous tumors. These biocompatible particles contain chemotherapeutic agents which deliver tumor-killing drugs to affected areas via sustained release over time in order to reduce side effects of traditional treatments and improve outcomes. They have been approved by FDA for use as an alternative treatment option for patients with colorectal cancer who cannot undergo surgery or radiation therapy due to their health conditions like severe chronic obstructive pulmonary disease (COPD), heart failure (HF), advanced age (> 75 years old) or other serious comorbidities such as diabetes mellitus (DM). oncozene Beads consist of either single-drug coated beads or multi-drug coated beads. They are available in both soft shell (polymer) and hard shell (ceramic) varieties depending upon dosage requirements.
Quadra sphere consists of four spherical beads, each with its own release rate and polymer coating for the therapeutic agent. quadra spheres are used to treat cancerous tumors in patients who have difficulty undergoing surgery or other treatment options due to their health conditions. The technology behind this product offers increased convenience as it eliminates the need for doctors to administer multiple injections at different points on a patient’s tumor site during surgical procedures.
LC beads are a type of drug-eluting bead that is coated with liquid-crystal polymer. They are biocompatible particles that contain a therapeutic agent and coated with an outer layer of polymer. The unique structure and properties of LC coating allow for prolonged release, as well as protection from degradation. This makes it an ideal candidate for the treatment of cancerous cells lodged in difficult to reach or sensitive areas such as brain tumors.
On the basis of application drug-eluting beads are segmented into hospitals, specialized clinics, research centers, and ambulatory surgical centers.
Drug-eluting beads have been used in hospitals since the 1970s for a variety of purposes. They were first designed to aid and prolong surgery by reducing bleeding, infection rates, and post-surgical recovery time. As they became more advanced over time, drug-eluting bead technology has also helped doctors perform minimally invasive surgeries with less pain due to reduced scarring or adhesion formation. For patients who need immediate relief from inflammation caused by wounds or fractures that are difficult to heal on their own, hydrogels may be useful as an alternative treatment option while waiting for other procedures like bone grafting or joint replacement surgery.
Drug-eluting beads in specialized clinics are used to stimulate the growth of new bone tissue. This is done by inserting a drug-coated balloon into an area where there has been damage due to trauma, tumor removal, or other causes that have led to the loss of healthy supporting bone. The bead contains osteogenic drugs like BMPs and IGFs which promote the production of new cells from existing ones in order to form new bones. These agents encourage cell division and differentiation so that they can eventually replace lost tissues with newly formed bony structures better able to support their weight and help maintain muscle activity levels during physical therapy sessions.
Drug-eluting beads are also used in research centers where they provide the ability to more precisely control and monitor levels of drug release. This is especially useful when researchers want to explore how different doses affect cell proliferation or need a controlled environment for experiments with live cells. Traditionally, this type of experimentation was done on animals but thanks to advances in technology it can now be conducted using human cells without harming an animal. In addition to benefiting academic institutions that perform research into biomedicine, these advancements could mean cheaper costs for developing drugs with potential market success because fewer prototypes will have been tested on animals before coming onto the commercial market. In turn, this would reduce dependence on laboratory animals as well as lower associated regulatory costs related to animal welfare.
The use of drug-eluting beads in ambulatory surgical centers is widely used to treat a number of cancers. The application provides an opportunity to administer the treatment via a catheter, which can be inserted into any part of the body through a small incision and for short periods without compromising on efficacy or side effects. This helps patients who cannot get surgery due to other health conditions such as heart disease and diabetes making it easy for them to receive therapies that they may not have otherwise been able to afford or access easily before.
On the basis of region, the drug-eluting market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
North America is expected to dominate the drug-eluting market in near future due to the high prevalence of cancer cases coupled with high awareness about new therapies such as hormone therapy among people living there which will result in greater demand for medical devices used for treatment. Asia Pacific region follows closely behind North American region followed by Europe owing to a rapid increase in the number of incidences of diseases along with the increasing level of investment in research activities.
The growth factors of the drug-eluting market are increasing awareness among the people about various types of treatment and a rise in demand for minimally invasive surgery. The major factor driving this growth is a rise in cancer rates, which has led to an increase in surgical procedures such as radiotherapy, chemotherapy, and proton therapy.
Up Market Research published a new report titled “Drug Eluting Beads Market research report which is segmented by Types (Oncozene Beads, Quadra Sphere, LC Beads, Others), By Applications (Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers), By Players/Companies Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo”.
|Drug Eluting Beads Market Research Report
|Oncozene Beads, Quadra Sphere, LC Beads, Others
|Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers
|Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo
|North America, Europe, APAC, Latin America, MEA
|2018 to 2019 (Data from 2010 can be provided as per availability)
|Number of Pages
|Number of Tables & Figures
|Yes, the report can be customized as per your need.
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Oncozene Beads, Quadra Sphere, LC Beads, Others and By Application Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers.
Some of the companies that are profiled in this report are:
Drug Eluting Beads Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Drug Eluting Beads Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Drug Eluting Beads Market Report:
Some other reports from this category!